We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cobra Biologics, Touchlight Collaborate

News   Jun 07, 2016

 
Cobra Biologics, Touchlight Collaborate
 
 
 

RELATED ARTICLES

‘Shortcut’ Transforms Terpene Biosynthesis in E. Coli

News

Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.

READ MORE

Concern Over Fake ISO 9001 Accreditation of Chinese Companies

News

A study concludes that fake ISO 9001 quality certificates are very widespread across Chinese companies and that the certification processes of the auditing companies lack credibility.

READ MORE

Errant Editing Enzyme Promotes Tumor Suppressor Loss and Leukemia Propagation

News

Detection of 'copy editing' by a stem cell enzyme called ADAR1 (active in more than 20 tumor types) may act as a molecular radar for early detection of malignancies, and represent a new therapeutic target.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE